Mercer Global Advisors Inc. ADV Reduces Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Mercer Global Advisors Inc. ADV lessened its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRGGet Rating) by 17.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,516 shares of the medical equipment provider’s stock after selling 2,921 shares during the quarter. Mercer Global Advisors Inc. ADV’s holdings in Intuitive Surgical were worth $4,856,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently bought and sold shares of ISRG. Hexagon Capital Partners LLC increased its position in Intuitive Surgical by 200.0% during the 4th quarter. Hexagon Capital Partners LLC now owns 69 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 46 shares in the last quarter. Paragon Capital Management Ltd purchased a new stake in Intuitive Surgical during the 4th quarter worth about $26,000. Wolff Wiese Magana LLC increased its position in Intuitive Surgical by 1,000.0% during the 4th quarter. Wolff Wiese Magana LLC now owns 77 shares of the medical equipment provider’s stock worth $28,000 after purchasing an additional 70 shares in the last quarter. Sargent Bickham Lagudis LLC increased its position in Intuitive Surgical by 200.0% during the 4th quarter. Sargent Bickham Lagudis LLC now owns 78 shares of the medical equipment provider’s stock worth $28,000 after purchasing an additional 52 shares in the last quarter. Finally, Amplius Wealth Advisors LLC purchased a new stake in Intuitive Surgical during the 4th quarter worth about $28,000. Hedge funds and other institutional investors own 44.03% of the company’s stock.

Shares of NASDAQ ISRG traded up $17.87 during trading on Tuesday, reaching $294.22. The stock had a trading volume of 46,623 shares, compared to its average volume of 2,051,824. Intuitive Surgical, Inc. has a one year low of $254.20 and a one year high of $369.69. The stock has a market cap of $105.68 billion, a PE ratio of 59.22, a P/E/G ratio of 7.12 and a beta of 1.17. The firm’s 50 day moving average price is $286.67 and its two-hundred day moving average price is $320.26.

Intuitive Surgical (NASDAQ:ISRGGet Rating) last issued its quarterly earnings results on Thursday, January 20th. The medical equipment provider reported $1.04 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $1.04. Intuitive Surgical had a return on equity of 15.33% and a net margin of 29.85%. The business had revenue of $1.55 billion during the quarter, compared to the consensus estimate of $1.54 billion. During the same period in the previous year, the business earned $1.01 EPS. The business’s quarterly revenue was up 16.6% on a year-over-year basis. On average, sell-side analysts expect that Intuitive Surgical, Inc. will post 3.93 earnings per share for the current year.

In related news, EVP Myriam Curet sold 2,478 shares of the business’s stock in a transaction that occurred on Wednesday, February 16th. The stock was sold at an average price of $289.00, for a total transaction of $716,142.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Robert Desantis sold 1,410 shares of the business’s stock in a transaction that occurred on Tuesday, January 25th. The shares were sold at an average price of $261.64, for a total value of $368,912.40. The disclosure for this sale can be found here. Insiders own 0.90% of the company’s stock.

A number of research firms recently commented on ISRG. UBS Group upgraded Intuitive Surgical from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $317.00 to $325.00 in a research report on Wednesday, February 2nd. Redburn Partners lowered Intuitive Surgical from a “buy” rating to a “neutral” rating in a research note on Tuesday, January 25th. BTIG Research decreased their price target on Intuitive Surgical from $372.00 to $360.00 and set a “buy” rating on the stock in a research note on Friday, January 21st. Robert W. Baird decreased their price target on Intuitive Surgical from $370.00 to $315.00 and set an “outperform” rating on the stock in a research note on Friday, January 21st. Finally, Evercore ISI decreased their price target on Intuitive Surgical from $340.00 to $290.00 and set an “inline” rating on the stock in a research note on Friday, January 21st. Eight analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical has an average rating of “Buy” and an average target price of $332.87.

Intuitive Surgical Profile (Get Rating)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

See Also

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGGet Rating).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.